GlassScriptPhysician profile
Klaudio Alla
NPI 1659991040
$1,634.56
in general payments reported to CMS, 2019-2025
9 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what 95% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $71.17 · 2024: $33.40 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,138 · Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,138.07 |
| Food and Beverage | $496.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,138.07 | 2025 | |
| Cook Medical LLC | $212.45 | 2025 | Blue Rhino |
| United Therapeutics Corporation | $91.46 | 2024-2025 | Tyvaso |
| Janssen Pharmaceuticals, INC | $71.17 | 2023 | Xarelto |
| Verona Pharma, INC. | $51.60 | 2025 | Ohtuvayre |
| Genzyme Corporation | $24.35 | 2025 | |
| Mylan Specialty L.P. | $16.35 | 2024 | Yupelri |
| Pulmonx Corporation | $15.44 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Astrazeneca Pharmaceuticals LP | $13.67 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Klaudio Alla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.